J&J, Basilea May Strike Deal On Phase III Antibiotic; FTC Pre-Approves
This article was originally published in The Pink Sheet Daily
Executive Summary
Ortho-McNeil and Basilea could partner on a broad-spectrum Phase III cephalosporin antibiotic, ceftobiprole (BAL5788)